Changzhou Qianhong Biopharma CO.,LTD

SZSE:002550.SZ

5.06 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income 181.861319.911186.343-147.627256.913211.045174.909224.683262.292242.156181.689158.722152.248150.524125.69390.37845.583
Depreciation & Amortization 69.21864.76369.43170.2565.47161.40961.37327.53720.49121.31421.58217.20812.88411.05210.92910.2619.92
Deferred Income Tax 02.4236.071-69.225-17.147-3.7250.02-0.675-9.2100000000
Stock Based Compensation 04.3754.1234.0662.0732.15900000000000
Change In Working Capital 292.314-382.733-109.999-9.911-109.123-140.164-66.641-44.633-0.498-12.651-52.38217.645-23.099-0.271-134.396-56.493-23.865
Accounts Receivables 420.4-165.89755.37349.779-120.749-71.805-24.73347.14-22.315-86.657-15.792-29.89200000
Inventory -77.458-136.123-84.788-73.032-0.038-50.775-25.48-58.63124.17847.595-36.35650.22116.572-16.694-115.579-45.804-15.169
Accounts Payables -50.628-83.136-86.65582.56728.811-13.859-16.449-32.4676.84900000000
Other Working Capital -02.4236.071-69.225-17.147-89.389-41.16113.998-24.676-60.246-16.026-32.576-39.67116.423-18.817-10.689-8.696
Other Non Cash Items -10.065-80.213-52.409469.724-36.64-106.844-81.12213.4284.2191.1949.5836.2484.78810.216.12410.2134.355
Operating Cash Flow 533.328-71.474103.561317.278161.54825.44688.519221.015286.504252.013160.472199.824146.82171.5158.3554.35935.994
Investing Activities:
Investments In Property Plant And Equipment -100.332-70.989-90.375-62.534-100.678-103.531-87.627-138.935-215.775-90.526-127.592-64.201-26.31-10.638-13.368-7.406-6.97
Acquisitions Net 0-1.6670.0030.0161.7032.9870.055-18.072-8.5000.054010.641000
Purchases Of Investments -104.517-155.2-39.821-10.204-6.35-1,543.115-1,636.0890.0270.00500-1.5840-0.03000
Sales Maturities Of Investments 1.43337.4338.4332.16993.778134.401129.0360.2690.4080.4270.0230.0230.0230.020.03500
Other Investing Activites 28.3190.443217.044500.088196.573259.88949.035-44.695-225.61-521.574-609.75-194.7714.125-10.6380.0450.021.783
Investing Cash Flow -175.097-189.97995.281459.535185.026290.75990.444-201.406-449.473-611.674-737.319-260.478-22.162-10.645-13.288-7.386-5.187
Financing Activities:
Debt Repayment -44.49121.2740-302.389-88.1248.04111.3190279235-29-55-323321.8534
Common Stock Issued 000.194171.84309.518000000000000
Common Stock Repurchased -30.0940-0.194-0.303-309.518-28.412-450000000000
Dividends Paid -152.976-149.976-149.976-303.969-152.877-123.828-118.349-110.833-104.05-80.557-80.214-57.635-42.408-123.504-43.39-35.829-6.734
Other Financing Activities 36.687139.71945.995171.84-326.7773.2218.722664-0001,216.31919.60400-0
Financing Cash Flow -190.87311.017-104.174-444.471-567.774-100.979-133.308-44.833178.95-57.557-75.214-86.6351,118.911-135.9-10.39-13.97927.266
Other Information:
Effect Of Forex Changes On Cash -1.59641.8877.39-18.5994.36617.853-6.1325.1085.070.894-5.784-0.514-2.856-1.579-0.37-1.318-2.131
Net Change In Cash 165.762-208.549102.057313.743-216.833233.07939.523-20.11521.052-416.324-657.844-147.8031,240.71323.391-15.69731.67655.942
Cash At End Of Period 575.018409.257617.806515.749202.006418.839185.76146.237166.353145.301561.6241,219.4691,364.023123.30999.918115.61583.94